チェコ共和国の経腸栄養市場の規模と予測（2021年 - 2031年）、世界および地域のシェア、傾向、成長機会分析レポートの対象範囲：製品タイプ別（経鼻胃管、経鼻腸管、シッピング、その他）
経腸栄養、または「経管栄養」は、胃または小腸に挿入された栄養チューブを使用して、消化管に直接栄養を与えます。経腸栄養は、タンパク質、炭水化物、脂肪、ビタミン、ミネラルなどのすべての必須栄養素を含む液体食品混合物で構成されています。調合食品は、そのまま飲める液体、粉末または濃縮混合物、またはブレンド食品です。乳児の場合、母乳または乳児用調合食品も、栄養チューブを介して与えられる場合は EN と見なされます。
一般的なまたは標準的な栄養調合食品は、体が正しく機能するために必要な量の栄養素を患者に正確に提供できない場合があります。そのため、医師は病気に特化した栄養製品を処方します。腎臓用処方は、標準処方よりもカロリーが高く、リン、カリウム、マグネシウムの濃度が低くなっています。同様に、肺用処方は、標準処方よりも炭水化物含有量が少ないのが特徴です。製薬会社は、個々の患者のニーズを満たすために、患者ごとに調整された成分（患者固有）を含む経腸栄養剤を提供しています。たとえば、Impact（ネスレ提供）は、一次選択手術患者の管理に臨床的に実証された栄養ソリューションであり、術後合併症や入院期間の短縮に役立ちます。糖尿病、腎不全、がんなどの病気の罹患率の増加により、チェコ共和国では病気固有の処方に対する需要が高まっています。
在宅経腸栄養剤の成長は、チェコ共和国の経腸栄養剤市場規模の拡大に貢献する注目すべき要因です。在宅経腸栄養剤により、患者は自宅で快適に栄養療法を続けることができ、入院期間が短縮され、医療費が最小限に抑えられます。チェコの医療制度は在宅ケアを重視しているため、病院のインフラへの負担が軽減され、在宅経腸栄養剤の需要が生まれています。在宅での栄養補給をよりアクセスしやすく、効果的にする技術の進歩は、在宅での経腸栄養の支持につながっています。たとえば、携帯可能な栄養ポンプや、より小型で使いやすい栄養チューブにより、患者は常時医師の監督を受けることなく、自宅で栄養を摂取することができます。自宅で治療を受けられる利便性と快適さにより、HEN は多くの患者とその家族にとって望ましい選択肢になると予想されています。
製品タイプに基づく洞察
チェコ共和国の経腸栄養市場は、タイプ別に、経鼻胃管、経鼻腸管、経口摂取、その他に分類されています。経鼻胃管セグメントは、2023 年にチェコ共和国の経腸栄養市場で最大のシェアを占め、2023 年から 2031 年にかけて最高の CAGR を記録すると予想されています。経鼻胃管栄養は、鼻から胃に小さなチューブを挿入するものであり、嚥下困難、神経障害、または経口摂取を妨げる重篤な症状に直面している患者に栄養を提供するためのシンプルで費用対効果の高いソリューションを提供します。経鼻胃管栄養は、患者が病気から回復するのに十分な栄養を摂取するのに役立ちます。経鼻胃管栄養は、短期的な栄養補給を必要とする患者に一般的に処方されます。
チェコ共和国における経鼻胃管栄養の需要は、脳卒中、パーキンソン病、嚥下に影響するその他の疾患などの神経疾患の発生率の増加によって推進されています。さらに、同国の人口の高齢化により、特に手術後や慢性疾患の管理において栄養補給を必要とする患者数が増加しています。医療インフラの改善と、より安全で高度な NG 栄養チューブ システムが利用できるようになったことも、経鼻胃管栄養の採用を促進しています。
チェコ共和国の経腸栄養市場レポートを作成する際に参照された一次および二次情報源には、経済協力開発機構、国際美容外科学会、世界保健機関などがあります。
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Czech Republic Enteral Nutrition Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Czech Republic Enteral Nutrition Market – Key Market Dynamics
5.1 Czech Republic Enteral Nutrition Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Increasing Prevalence of Chronic Diseases
5.2.2 Rising Aging Population
5.3 Market Restraints
5.3.1 High Cost of Enteral Nutrition
5.4 Market Opportunities
5.4.1 Growth of Home Enteral Nutrition
5.5 Future Trends
5.5.1 Personalized Enteral Nutrition Therapy
5.6 Impact of Drivers and Restraints:
6. Czech Republic Enteral Nutrition Market Analysis
6.1 Czech Republic Enteral Nutrition Market Revenue (US$ Million), 2021–2031
6.2 Czech Republic Enteral Nutrition Market Forecast and Analysis
6.3 Czech Republic Enteral and Parenteral Nutrition Market Value (%)
7. Czech Republic Enteral Nutrition Market Analysis – by Product Type
7.1 Nasogastric
7.1.1 Overview
7.1.2 Nasogastric: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.1.3 Standard
7.1.3.1 Overview
7.1.3.2 Standard: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.1.4 Disease Specific
7.1.4.1 Overview
7.1.4.2 Disease Specific: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Nasoenteral
7.2.1 Overview
7.2.2 Nasoenteral: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Sipping
7.3.1 Overview
7.3.2 Sipping: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8. Czech Republic Enteral Nutrition Market – Country Analysis
8.1 Europe
8.1.1 Czech Republic Enteral Nutrition Market
8.1.1.1 Czech Republic Enteral Nutrition Market Revenue and Forecast and Analysis – by Country
8.1.1.2 Czech Republic: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8.1.1.2.1 Czech Republic: Czech Republic Enteral Nutrition Market Breakdown by Product Type
8.1.1.2.2 Czech Republic: Czech Republic Enteral Nutrition Market Breakdown by Nasogastric Type
8.1.1.2.3 Czech Republic: Czech Republic Enteral Nutrition Market Breakdown by Standard By Calories
8.1.1.2.4 Czech Republic: Czech Republic Enteral Nutrition Market Breakdown by Isocaloric
8.1.1.2.5 Czech Republic: Czech Republic Enteral Nutrition Market Breakdown by Hypercaloric
8.1.1.2.6 Czech Republic: Czech Republic Enteral Nutrition Market Breakdown by Standard By Type
8.1.1.2.7 Czech Republic: Czech Republic Enteral Nutrition Market Breakdown by Standard By End user
9. Company Profiles
9.1 Nestle SA
9.1.1 Key Facts
9.1.2 Business Description
9.1.3 Products and Services
9.1.4 Financial Overview
9.1.5 SWOT Analysis
9.1.6 Key Developments
9.2 Danone SA
9.2.1 Key Facts
9.2.2 Business Description
9.2.3 Products and Services
9.2.4 Financial Overview
9.2.5 SWOT Analysis
9.2.6 Key Developments
9.3 Abbott Laboratories
9.3.1 Key Facts
9.3.2 Business Description
9.3.3 Products and Services
9.3.4 Financial Overview
9.3.5 SWOT Analysis
9.3.6 Key Developments
9.4 Royal FrieslandCampina NV
9.4.1 Key Facts
9.4.2 Business Description
9.4.3 Products and Services
9.4.4 Financial Overview
9.4.5 SWOT Analysis
9.4.6 Key Developments
9.5 Fresenius SE & Co KGaA
9.5.1 Key Facts
9.5.2 Business Description
9.5.3 Products and Services
9.5.4 Financial Overview
9.5.5 SWOT Analysis
9.5.6 Key Developments
9.6 B Braun SE
9.6.1 Key Facts
9.6.2 Business Description
9.6.3 Products and Services
9.6.4 Financial Overview
9.6.5 SWOT Analysis
9.6.6 Key Developments
9.7 Reckitt Benckiser Group Plc
9.7.1 Key Facts
9.7.2 Business Description
9.7.3 Products and Services
9.7.4 Financial Overview
9.7.5 SWOT Analysis
9.7.6 Key Developments
9.8 Kate Farms Inc
9.8.1 Key Facts
9.8.2 Business Description
9.8.3 Products and Services
9.8.4 Financial Overview
9.8.5 SWOT Analysis
9.8.6 Key Developments
9.9 Dr Schar AG
9.9.1 Key Facts
9.9.2 Business Description
9.9.3 Products and Services
9.9.4 Financial Overview
9.9.5 SWOT Analysis
9.9.6 Key Developments
9.10 Fonterra Co-Operative Group Ltd
9.10.1 Key Facts
9.10.2 Business Description
9.10.3 Products and Services
9.10.4 Financial Overview
9.10.5 SWOT Analysis
9.10.6 Key Developments
9.11 Perrigo Co Plc
9.11.1 Key Facts
9.11.2 Business Description
9.11.3 Products and Services
9.11.4 Financial Overview
9.11.5 SWOT Analysis
9.11.6 Key Developments
9.12 Arla Foods amba
9.12.1 Key Facts
9.12.2 Business Description
9.12.3 Products and Services
9.12.4 Financial Overview
9.12.5 SWOT Analysis
9.12.6 Key Developments
9.13 Charing Cross Scientific AS
9.13.1 Key Facts
9.13.2 Business Description
9.13.3 Products and Services
9.13.4 Financial Overview
9.13.5 SWOT Analysis
9.13.6 Key Developments
9.14 Bexen Medical
9.14.1 Key Facts
9.14.2 Business Description
9.14.3 Products and Services
9.14.4 Financial Overview
9.14.5 SWOT Analysis
9.14.6 Key Developments
10. Appendix
10.1 About The Insight Partners
10.2 Glossary of Terms
List of Tables
Table 1. Czech Republic Enteral Nutrition Market Segmentation
Table 2. Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Table 3. Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 4. Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Country
Table 5. Czech Republic: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 6. Czech Republic: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Nasogastric Type
Table 7. Czech Republic: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Calories
Table 8. Czech Republic: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Isocaloric
Table 9. Czech Republic: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Hypercaloric
Table 10. Czech Republic: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By Type
Table 11. Czech Republic: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million) – by Standard By End user
Table 12. Glossary of Terms, Czech Republic Enteral Nutrition Market
List of Figures
Figure 1. Czech Republic Enteral Nutrition Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Czech Republic Enteral Nutrition Market Revenue (US$ Million), 2021–2031
Figure 5. Czech Republic Enteral Nutrition Market Share (%) – by Product Type, 2023 and 2031
Figure 6. Nasogastric: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Standard: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Disease Specific: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Nasoenteral: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Sipping: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Others: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Czech Republic: Czech Republic Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
- Nestle SA
- Danone SA
- Abbott Laboratories
- Royal FrieslandCampina NV
- Fresenius SE & Co KGaA
- B Braun SE
- Reckitt Benckiser Group Plc
- Kate Farms Inc
- Dr Schar AG
- Fonterra Co-Operative Group Ltd
- Perrigo Co Plc
- Arla Foods amba
- Charing Cross Scientific AS
- Bexen Medical
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Czech Republic enteral nutrition market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Czech Republic enteral nutrition market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.